Free Trial
The Market Does Not Wait. MarketBeat All Access Alerts for $149
Get the Alerts
Claim MarketBeat All Access Sale Promotion
NASDAQ:AMIX

Autonomix Medical Q2 2027 Earnings Date & Estimates

Autonomix Medical logo
$2.42 0.00 (0.00%)
Closing price 10/23/2026 03:59 PM Eastern
Extended Trading
$2.43 +0.01 (+0.29%)
As of 04:55 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Autonomix Medical is estimated to report Q2 2027 earnings on Wednesday, November 11, 2026. The conference call is scheduled for November 9, 2026 at 9:30 AM ET.

Research:ProfileEarnings HistoryForecast

Upcoming Earnings Announcement

Quarter
Q2 2027
Announcement Date
Conference Call Date
Conference Call
9:30 AM ET
Google Calendar (opens in a new tab)Outlook (opens in a new tab)Yahoo Calendar (opens in a new tab)

What Analysts Expect from Autonomix Medical in Q2 2027

Autonomix Medical is expected to post earnings of -$2.62 per share. In the same quarter a year earlier Autonomix Medical reported -$28.98 per share. Autonomix Medical last reported on August 12, 2026, posting -$5.02 per share and beating the -$6.40 consensus estimate. Autonomix Medical has beaten the consensus EPS estimate in 2 of its last 4 quarters.

Consensus Estimates

Consensus EPS
-$2.62
Prior-Year EPS
-$28.98

Recent Track Record

Last Reported
Q1 2027
Last Quarter EPS
-$5.02 (Beat by +$1.38)
EPS Beat Rate
2 of last 4 quarters

Prepare for the Q2 2027 Call

Autonomix Medical Q2 2027 Earnings FAQ

Autonomix Medical (NASDAQ:AMIX) is estimated to report Q2 2027 earnings on Wednesday, November 11, 2026. This date is estimated from past reporting schedules and may change once the company confirms it.

Autonomix Medical's Q2 2027 earnings conference call is scheduled for Monday, November 9, 2026 at 9:30 AM ET. MarketBeat streams the conference call audio and posts the transcript as soon as possible on the earnings announcement date.

Analysts expect Autonomix Medical to post earnings of -$2.62 per share for Q2 2027.

Autonomix Medical Earnings Headlines

Autonomix Medical consensus price target lowered by 30.61% to $41.62
October 22, 2026  |  msn.comhttps://www.msn.com/en-us/technology/tech-companies/autonomix-medical-consensus-price-target-lowered-by-30-61-to-41-62/ar-AA2fQZhD
Autonomix Medical, Inc. (AMIX) Receives a Buy from Maxim Group
October 18, 2026  |  theglobeandmail.comhttps://www.theglobeandmail.com/investing/markets/markets-news/Tipranks/8171411/autonomix-medical-inc-amix-receives-a-buy-from-maxim-group/
Trump’s Plan To Cheat History
China has slashed its U.S. Treasury holdings by more than 45% from their peak, while building gold vaults and payment networks that bypass the dollar entirely. Since the Federal Reserve opened in 1913, the dollar has lost most of its purchasing power. Porter Stansberry argues a new monetary order is forming around AI infrastructure, chips and energy, pointing to stocks like Vertiv, GE Vernova and Arista Networks that have surged hundreds of percent in recent years.tc pixel
 |  Porter & Company (Ad)
Autonomix Medical Strengthens Patent Protection for Platform Technology Enabling Precision Access, Treatment Delivery and Procedural Validation
October 2, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/10/02/3373785/0/en/autonomix-medical-strengthens-patent-protection-for-platform-technology-enabling-precision-access-treatment-delivery-and-procedural-validation.html
Autonomix Medical Completes FDA Pre-Submission Meeting On Standalone Transvascular Sensing Platform
September 30, 2026  |  rttnews.comhttps://www.rttnews.com/3695378/autonomix-medical-completes-fda-pre-submission-meeting-on-standalone-transvascular-sensing-platform.aspx
Autonomix Reports Positive FDA Feedback Supporting 510(k) Pathway to U.S. Clearance
September 30, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/09/30/3371859/0/en/autonomix-reports-positive-fda-feedback-supporting-510-k-pathway-to-u-s-clearance.html
See More Autonomix Medical Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Autonomix Medical? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Autonomix Medical and other key companies, straight to your email.

About Autonomix Medical

Autonomix Medical (NASDAQ:AMIX) is a clinical-stage medical device company developing catheter-based technologies for the diagnosis and treatment of conditions involving the peripheral and autonomic nervous systems. Its platform is designed to help physicians identify and access nerves during minimally invasive procedures.

The company’s technology incorporates a miniature sensor into a catheter to detect neural signals in real time. Autonomix is initially focused on applications in pain management, including procedures intended to treat pain associated with pancreatic cancer, while also evaluating broader uses in chronic pain and other conditions involving abnormal nerve activity.

Autonomix Medical’s products are in the development and clinical-evaluation stages, and the company’s technology may require additional testing, regulatory review and approval before broader commercialization. Publicly available information provides limited detail about its commercial geographic reach and operating history.

View Autonomix Medical Profile
Earnings Tools